Causes of death after therapy for early stage Hodgkin's disease entered on EORTC protocols
- 1 November 1990
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 19 (5) , 1155-1157
- https://doi.org/10.1016/0360-3016(90)90221-5
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin's disease. The EORTC Lymphoma Group controlled clinical trials: 1964-1987Blood, 1989
- Intercurrent Death after Hodgkin Disease Therapy in Radiotherapy and Adjuvant MOPP TrialsAnnals of Internal Medicine, 1988
- Risk of Second Cancers after Treatment for Hodgkin's DiseaseNew England Journal of Medicine, 1988
- Major complications and causes of death in patients treated for Hodgkin's disease.Journal of Clinical Oncology, 1987
- Hodgkin's disease: Is there a price for successful treatment? A 25-year experienceInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Coronary heart disease mortality after irradiation for Hodgkin's diseaseCancer, 1982
- Five-year results of the E.O.R.T.C. randomized study of splenectomy and spleen irradiation in clinical stages I and II of Hodgkin's diseasePublished by Elsevier ,1981
- A randomized study of irradiation and vinblastine in stages I and II of Hodgkin's disease: Preliminary resultsPublished by Elsevier ,1972